Examination of the neurofilament light chain in the blood of patients with multiple sclerosis

被引：0
|
作者：
Turcani, P. [1 ]
Vitkova, M. [2 ]
机构：
[1] LF UK UN Bratislava, Neurol Klin 1, Pazitkova 4, Bratislava 82101, Slovakia
[2] UNLP Kosice, Neurol Klin, LF UPJS, Kosice, Slovakia
来源：
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE | 2023年 / 86卷 / 04期
关键词：
D O I：
10.48095/cccsnn2023286
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
下载
收藏
页码：286 / 287
页数：2
相关论文
共 50 条
  • [31] Including Blood Neurofilament Light Chain in the NEDA Concept in Relapsing-Remitting Multiple Sclerosis Trials
    Sormani, Maria Pia
    Kappos, Ludwig
    Haring, Dieter
    Kropshofer, Harald
    Barro, Christian
    Leppert, David
    Tomic, Davorka
    Kuhle, Jens
    NEUROLOGY, 2018, 90
  • [32] Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis
    Engel, Sinah
    Protopapa, Maria
    Steffen, Falk
    Papanastasiou, Vakis
    Nicolaou, Christoforos
    Protopapas, Michalis
    Zipp, Frauke
    Bittner, Stefan
    Luessi, Felix
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [33] Blood neurofilament light chain levels are elevated in paediatric patients with multiple sclerosis and reduced under disease-modifying treatment
    Reinert, M. -C.
    Kropshofer, H.
    Barro, C.
    Wuerfel, J.
    Benkert, P.
    Michalak, Z.
    Brueck, W.
    Huppke, P.
    Tomic, D.
    Leppert, D.
    Kuhle, J.
    Gaertner, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 1023 - 1023
  • [34] Blood Neurofilament Light Chain Levels and Association with Brain Volume Change in Patients with Primary Progressive Multiple Sclerosis and Relapsing Multiple Sclerosis Before and During Ocrelizumab Treatment
    Jia, Xiaoming
    Herman, Ann
    Harp, Christopher
    Cross, Anne
    Fiore, Damian
    Hauser, Stephen
    Kappos, Ludwig
    Koendgen, Harold
    Kuhle, Jens
    Leppert, David
    Manfrini, Marianna
    Model, Fabian
    Oksenberg, Jorge
    Sauter, Annette
    Thanei, Gian-Andrea
    Bar-Or, Amit
    NEUROLOGY, 2020, 94 (15)
  • [35] Blood neurofilament light levels segregate treatment effects in multiple sclerosis
    Delcoigne, Benedicte
    Manouchehrinia, Ali
    Barro, Christian
    Benkert, Pascal
    Michalak, Zuzanna
    Kappos, Ludwig
    Leppert, David
    Tsai, Jon A.
    Plavina, Tatiana
    Kieseier, Bernd C.
    Lycke, Jan
    Alfredsson, Lars
    Kockum, Ingrid
    Kuhle, Jens
    Olsson, Tomas
    Piehl, Fredrik
    NEUROLOGY, 2020, 94 (11) : E1201 - E1212
  • [36] Neurofilament light chains in serum in biopsied multiple sclerosis patients
    Beutler, A-S.
    Kruse, N.
    Stork, L.
    Gloth, M.
    Brueck, W.
    Metz, I.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 10 - 10
  • [37] Vitamin D3 supplementation and neurofilament light chain in multiple sclerosis
    Smolders, Joost
    Mimpen, Max
    Oechtering, Johanna
    Damoiseaux, Jan
    van den Ouweland, Jody
    Hupperts, Raymond
    Kuhle, Jens
    ACTA NEUROLOGICA SCANDINAVICA, 2020, 141 (01): : 77 - 80
  • [38] CSF neurofilament light chain provides a valuable prognostic tool in multiple sclerosis
    Leitao, M. J.
    Pascoal, R.
    Ribeiro, M. H.
    Correia, I.
    Batista, S.
    Sousa, L.
    Baldeiras, I.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 835 - 836
  • [39] Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis
    Ning, Liangxia
    Wang, Bin
    PLOS ONE, 2022, 17 (09):
  • [40] The association between serum neurofilament light chain and OCT measures in multiple sclerosis
    Hagemeier, Jesper
    Tavazzi, Eleonora
    Ramanathan, Murali
    Jakimovski, Dejan
    Bergsland, Niels
    Tomic, Davorka
    Kropshofer, Harald
    Leppert, David
    Michalak, Zuzanna
    Dwyer, Michael
    Benedict, Ralph
    Weinstock-Guttman, Bianca
    Kuhle, Jens
    Zivadinov, Robert
    NEUROLOGY, 2019, 92 (15)
12345